Meningioma: not always a benign tumor. A review of advances in the treatment of meningiomas

I Maggio, E Franceschi, A Tosoni, VD Nunno… - CNS …, 2021 - Taylor & Francis
Meningiomas are the most common primary intracranial tumors. The majority of
meningiomas are benign, but they can present different grades of dedifferentiation from …

Neurofibromatosis type 2

AR Asthagiri, DM Parry, JA Butman, HJ Kim, ET Tsilou… - The Lancet, 2009 - thelancet.com
Neurofibromatosis type 2 is an autosomal-dominant multiple neoplasia syndrome that
results from mutations in the NF2 tumour suppressor gene located on chromosome 22q. It …

Birth incidence and prevalence of tumor‐prone syndromes: estimates from a UK family genetic register service

DG Evans, E Howard, C Giblin, T Clancy… - American journal of …, 2010 - Wiley Online Library
Dominantly inherited tumor-prone syndromes are a significant health burden, but disease-
related morbidity can be reduced and life expectancy increased by a GR type approach …

Neurofibromatosis: a review of NF1, NF2, and schwannomatosis

JL Kresak, M Walsh - Journal of pediatric genetics, 2016 - thieme-connect.com
The neurofibromatoses are a heterogeneous group of hereditary cancer syndromes that
lead to tumors of the central and peripheral nervous systems, as well as other organ …

Neurofibromatosis type 2 (NF2): a clinical and molecular review

DGR Evans - Orphanet journal of rare diseases, 2009 - Springer
Abstract Neurofibromatosis type 2 (NF2) is a tumour-prone disorder characterised by the
development of multiple schwannomas and meningiomas. Prevalence (initially estimated at …

An update on the CNS manifestations of neurofibromatosis type 2

S Coy, R Rashid, A Stemmer-Rachamimov… - Acta …, 2020 - Springer
Neurofibromatosis type II (NF2) is a tumor predisposition syndrome characterized by the
development of distinctive nervous system lesions. NF2 results from loss-of-function …

Incidence of vestibular schwannoma and neurofibromatosis 2 in the North West of England over a 10-year period: higher incidence than previously thought

DGR Evans, A Moran, A King, S Saeed… - Otology & …, 2005 - journals.lww.com
Objective: To determine the incidence of vestibular schwannoma (VS) in sporadic,
neurofibromatosis type 2 (NF2) germ-line and mosaic form in a 10-year period. Study …

Diagnostic criteria for schwannomatosis

M MacCollin, EA Chiocca, DG Evans, JM Friedman… - Neurology, 2005 - AAN Enterprises
The neurofibromatoses are a diverse group of genetic conditions that share a predisposition
to the development of tumors of the nerve sheath. Schwannomatosis is a recently …

Current status and recommendations for imaging in neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis

S Ahlawat, JO Blakeley, S Langmead, AJ Belzberg… - Skeletal radiology, 2020 - Springer
Abstract Neurofibromatosis type 1 (NF1), neurofibromatosis type 2 (NF2), and
schwannomatosis (SWN) are three clinically distinct tumor predisposition syndromes with a …

An update on the diagnosis and treatment of vestibular schwannoma

J Halliday, SA Rutherford, MG McCabe… - Expert review of …, 2018 - Taylor & Francis
Introduction: Vestibular schwannomas (VS) account for approximately 85% of tumors in the
cerebello-pontine angle, with a lifetime incidence of approximately 1 in 1000. Most are …